100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes.

100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes.
复制标题

DOI:
10.1093/immadv/ltab024
复制
发表时间:
2021-01
影响因子:
--
通讯作者:
Walker LSK
Walker LSK
中科院分区:
其他
文献类型:
--
作者:
Pearson JA;McKinney EF;Walker LSK

文献摘要

参考文献

相似文献

1型糖尿病(T1D)是一种自身免疫性疾病,其特征是T细胞介导的胰腺中产生胰岛素的β细胞遭到破坏。与其他自身免疫性疾病类似,1型糖尿病的发病率在全球范围内呈上升趋势。100年前胰岛素的发现极大地改变了1型糖尿病患者的前景,使其不再是一种致命的疾病。在我们庆祝这一里程碑的百年之际,1型糖尿病的治疗选择再次处于一个转折点。多年来致力于开发免疫疗法的努力终于开始取得成效,在新发甚至预防方面都有进展的迹象。在此,我们综述了一些在保护β细胞功能方面显示出前景的免疫疗法,并强调了1型糖尿病环境下免疫疗法的未来考虑因素。
Type 1 diabetes (T1D) is an autoimmune disease characterised by T cell-mediated destruction of the insulin-producing β cells in the pancreas. Similar to other autoimmune diseases, the incidence of T1D is increasing globally. The discovery of insulin 100 years ago dramatically changed the outlook for people with T1D, preventing this from being a fatal condition. As we celebrate the centenary of this milestone, therapeutic options for T1D are once more at a turning point. Years of effort directed at developing immunotherapies are finally starting to pay off, with signs of progress in new onset and even preventative settings. Here, we review a selection of immunotherapies that have shown promise in preserving β cell function and highlight future considerations for immunotherapy in the T1D setting.
DOI: 10.2337/diabetes.42.1.44
发表时间: 1993-01-01
期刊: DIABETES
影响因子: 7.7
作者:
CHRISTIANSON, SW;SHULTZ, LD;LEITER, EH
通讯作者: LEITER, EH
DOI: 10.2337/db14-0365
发表时间: 2014-11
期刊: Diabetes
影响因子: 7.7
作者:
Arif S;Leete P;Nguyen V;Marks K;Nor NM;Estorninho M;Kronenberg-Versteeg D;Bingley PJ;Todd JA;Guy C;Dunger DB;Powrie J;Willcox A;Foulis AK;Richardson SJ;de Rinaldis E;Morgan NG;Lorenc A;Peakman M
通讯作者: Peakman M
DOI: 10.1155/2016/7569431
发表时间: 2016
影响因子: 4.3
作者:
Dolpady J;Sorini C;Di Pietro C;Cosorich I;Ferrarese R;Saita D;Clementi M;Canducci F;Falcone M
通讯作者: Falcone M
DOI: 10.1371/journal.pone.0188475
发表时间: 2017
期刊: PloS one
影响因子: 3.7
作者:
de Groot PF;Belzer C;Aydin Ö;Levin E;Levels JH;Aalvink S;Boot F;Holleman F;van Raalte DH;Scheithauer TP;Simsek S;Schaap FG;Olde Damink SWM;Roep BO;Hoekstra JB;de Vos WM;Nieuwdorp M
通讯作者: Nieuwdorp M
DOI: 10.1038/nm924
发表时间: 2003-09-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Belghith, M;Bluestone, JA;Chatenoud, L
通讯作者: Chatenoud, L